. | Patients With TS . | 46,XX Female Control Subjects . | 46,XY Male Control Subjects . |
---|---|---|---|
Total calls,a no. (95% CI) | 1818 (1807–1830) | 1842 (1828–1856) | 1743 (1726–1761) |
Heterozygous calls,a no. [% total] (95% CI) | 4 [0.22] (3.0–5.1) | 178 [9.6] (164–191) | 4.8 [0.27] (3.8–5.8) |
Individuals with Y-chromosome calls,b absolute no. | 1/27 | 0/37 | 27/27 |
. | Patients With TS . | 46,XX Female Control Subjects . | 46,XY Male Control Subjects . |
---|---|---|---|
Total calls,a no. (95% CI) | 1818 (1807–1830) | 1842 (1828–1856) | 1743 (1726–1761) |
Heterozygous calls,a no. [% total] (95% CI) | 4 [0.22] (3.0–5.1) | 178 [9.6] (164–191) | 4.8 [0.27] (3.8–5.8) |
Individuals with Y-chromosome calls,b absolute no. | 1/27 | 0/37 | 27/27 |
. | Patients With TS . | 46,XX Female Control Subjects . | 46,XY Male Control Subjects . |
---|---|---|---|
Total calls,a no. (95% CI) | 1818 (1807–1830) | 1842 (1828–1856) | 1743 (1726–1761) |
Heterozygous calls,a no. [% total] (95% CI) | 4 [0.22] (3.0–5.1) | 178 [9.6] (164–191) | 4.8 [0.27] (3.8–5.8) |
Individuals with Y-chromosome calls,b absolute no. | 1/27 | 0/37 | 27/27 |
. | Patients With TS . | 46,XX Female Control Subjects . | 46,XY Male Control Subjects . |
---|---|---|---|
Total calls,a no. (95% CI) | 1818 (1807–1830) | 1842 (1828–1856) | 1743 (1726–1761) |
Heterozygous calls,a no. [% total] (95% CI) | 4 [0.22] (3.0–5.1) | 178 [9.6] (164–191) | 4.8 [0.27] (3.8–5.8) |
Individuals with Y-chromosome calls,b absolute no. | 1/27 | 0/37 | 27/27 |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.